Neuroblastoma Research

Browse by Tags

• IFN-{beta} sensitizes neuroblastoma to the antitumor activity of temozolomide by modulating O6-methylguanine DNA methyltransferase expression.

  IFN-{beta} sensitizes neuroblastoma to the antitumor activity of temozolomide by modulating O6-methylguanine DNA methyltransferase expression. Mol Cancer Ther. 2008 Dec 3; Authors: Rosati SF, Williams RF, Nunnally LC, McGee MC, Sims TL, Tracey L, Zhou... Posted Dec 06 2008, 08:55 AM by PubMed: neuroblastoma Filed under: Mol Cancer Ther

• Antixenograft tumor activity of a humanized anti-insulin-like growth factor-I receptor monoclonal antibody is associated with decreased AKT activation and glucose uptake.

  Related Articles Antixenograft tumor activity of a humanized anti-insulin-like growth factor-I receptor monoclonal antibody is associated with decreased AKT activation and glucose uptake. Mol Cancer Ther. 2008 Sep;7(9):2599-608 Authors: Shang Y, Mao Y... Posted Sep 16 2008, 08:49 AM by PubMed: neuroblastoma Filed under: Mol Cancer Ther

• N-&-N, a new class of cell death-inducing kinase inhibitors derived from the purine roscovitine.

  Related Articles N-&-N, a new class of cell death-inducing kinase inhibitors derived from the purine roscovitine. Mol Cancer Ther. 2008 Sep;7(9):2713-24 Authors: Bettayeb K, Sallam H, Ferandin Y, Popowycz F, Fournet G, Hassan M, Echalier A, Bernard... Posted Sep 16 2008, 08:49 AM by PubMed: neuroblastoma Filed under: Mol Cancer Ther

• Topotecan inhibits vascular endothelial growth factor production and angiogenic activity induced by hypoxia in human neuroblastoma by targeting hypoxia-inducible factor-1{alpha} and -2{alpha}.

  Related Articles Topotecan inhibits vascular endothelial growth factor production and angiogenic activity induced by hypoxia in human neuroblastoma by targeting hypoxia-inducible factor-1{alpha} and -2{alpha}. Mol Cancer Ther. 2008 Jul;7(7):1974-84 Authors... Posted Jul 24 2008, 11:22 AM by PubMed: neuroblastoma Filed under: Mol Cancer Ther

• A rationally designed tyrosine hydroxylase DNA vaccine induces specific antineuroblastoma immunity.

  Related Articles A rationally designed tyrosine hydroxylase DNA vaccine induces specific antineuroblastoma immunity. Mol Cancer Ther. 2008 Jul;7(7):2241-51 Authors: Huebener N, Fest S, Strandsby A, Michalsky E, Preissner R, Zeng Y, Gaedicke G, Lode HN... Posted Jul 24 2008, 11:22 AM by PubMed: neuroblastoma Filed under: Mol Cancer Ther